Paradigm Biopharmaceuticals Limited
PBIGF
$0.2083
$0.00633.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.74% | 44.11% | 2.32% | -49.06% | 5.64% |
| Total Receivables | -10.74% | 30.33% | 2.32% | -34.53% | 5.64% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.74% | -9.24% | 2.32% | 46.67% | 5.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.74% | 38.36% | 2.31% | -44.53% | 5.64% |
|
|
|||||
| Total Current Assets | -10.74% | 38.36% | 2.31% | -44.53% | 5.64% |
| Net Property, Plant & Equipment | -10.74% | -35.26% | 2.26% | -31.01% | 5.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.75% | 3.92% | 2.32% | -4.34% | 5.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -10.74% | 34.14% | 2.32% | -41.82% | 5.64% |
|
|
|||||
| Total Accounts Payable | -10.73% | -78.61% | 2.32% | -72.97% | 5.64% |
| Total Accrued Expenses | -10.71% | 3.38% | 2.32% | -51.52% | 5.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.64% | -30.63% | 2.26% | 2.98% | 5.61% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -10.74% | -66.69% | 2.32% | -70.57% | 5.64% |
|
|
|||||
| Total Current Liabilities | -10.74% | -66.69% | 2.32% | -70.57% | 5.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.68% | -11.61% | 2.35% | -36.54% | 5.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.76% | 21.01% | 2.29% | -26.91% | 5.52% |
| Total Liabilities | -10.75% | -62.26% | 2.31% | -69.49% | 5.64% |
|
|
|||||
| Common Stock & APIC | -10.74% | 10.52% | 2.32% | -4.34% | 5.64% |
| Retained Earnings | 10.74% | -5.09% | -2.32% | 0.28% | -5.64% |
| Treasury Stock & Other | -10.74% | -34.69% | 2.32% | -17.42% | 5.64% |
| Total Common Equity | -10.74% | 48.66% | 2.32% | -32.62% | 5.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.74% | 48.66% | 2.32% | -32.62% | 5.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.74% | 48.66% | 2.32% | -32.62% | 5.64% |
|
|
|||||